Articles tagged with: Healthcare

27June

Hyris presented Hyris System, its distruptive signature technology, at Analytica 2022 in Munich

Hyris presented Hyris System, its distruptive signature technology, at Analytica 2022 in Munich

Hyris presented its Hyris System™ and the new T Cells test in Munich last week, at Analytica 2022, the world largest laboratory technology fair.

Posted in Events

13June

A new T-cell activation assay based on Hyris technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity.

A new T-cell activation assay based on Hyris technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity.

A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients’ immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris.

Posted in Products

21December

Hyris presented its new, disruptive T-Cell test at the international conference "A-Wish", fully embracing the Immunology sector to better fight COVID-19 and beyond.

Hyris presented its new, disruptive T-Cell test at the international conference

On December 17th 2021 Hyris presented its new test to detect the body's T Cell immune response to SARS-CoV-2 on 17 December 2021, at "A-WISH", Alicante-Winter Immunology Symposium in Health, which addressed strategies for the COVID-19 response and the development of the vaccines against SARS-CoV-2.

Posted in Products

02December

Hyris releases its new Demo to better support all prospect users of its portable and reliable molecular test for diagnosing SARS-CoV-2 into human subjects.

Hyris releases its new Demo to better support all prospect users of its portable and reliable molecular test for diagnosing SARS-CoV-2 into human subjects.

With the SARS-CoV-2 pandemic still causing further disruption of public security and companies’ workflows worldwide, Hyris keeps supporting medical professionals and researchers testing the presence of SARS-CoV-2 into human beings. A fresh, new demo immed

Posted in Products

14October

Hyris new Test can quickly detect the body's T Cell immune response to SARS-CoV-2.

Hyris new Test can quickly detect the body's T Cell immune response to SARS-CoV-2.

Hyris developed a rapid T-Cell test, which leverages the power of the Hyris SystemTM to track patients' immunity levels to SARS-CoV-2 for research and global clinical use. The new test has been brought to market after having inked an exclusive licensing agreement with Singapore Duke-NUS Medical School.

Posted in Products, Events

Newsletter

Subscribe our newsletter for periodical updates about Hyris solutions.

Address


Headquarter

London

Lower Ground Floor
One George Yard
EC3V 9DF - London, UK
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Center

Milan

Viale Lancetti 19
20158 Milan, Italy

  • This email address is being protected from spambots. You need JavaScript enabled to view it.

C.so Garibaldi 60
Milano 20121, Italy
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Hyris APAC - R&D Center of Excellence

Singapore

38 19 Cecil Street #04-01
The Quadrant at Cecil
Singapore (049704)
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

US West Coast Sales Inquiries

Los Gatos

  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Social